You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 20, 2025

Details for Patent: 10,507,180


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,507,180 protect, and when does it expire?

Patent 10,507,180 protects DSUVIA and is included in one NDA.

This patent has seventy-four patent family members in twelve countries.

Summary for Patent: 10,507,180
Title:Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
Inventor(s): Palmer; Pamela (San Francisco, CA), Schreck; Thomas (Portola Valley, CA), Tzannis; Stelios (Petaluma, CA), Hamel; Larry (Pacific Grove, CA), Poutiatine; Andrew I. (Mill Valley, CA)
Assignee: AcelRx Pharmaceuticals, Inc. (Redwood City, CA)
Application Number:16/153,301
Patent Claim Types:
see list of patent claims
Use; Delivery; Device; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,507,180: A Comprehensive Overview

Introduction

When delving into the world of patents, understanding the scope and claims of a particular patent is crucial for innovators, investors, and legal professionals. This article will provide a detailed analysis of the scope and claims of United States Patent 10,507,180, focusing on its key aspects, implications, and the broader patent landscape.

Understanding Patent Scope

Patent scope is a critical aspect of patent law, determining the breadth of protection granted to an invention. It is often measured through metrics such as independent claim length and independent claim count, as highlighted in research on patent scope[3].

Patent 10,507,180: Overview

To analyze the scope and claims of United States Patent 10,507,180, we need to consider the following elements:

Invention Description

This patent, though not explicitly detailed in the provided sources, typically involves a specific innovation or improvement in a field such as pharmaceuticals, medical devices, or related technologies.

Claims Structure

The claims section of a patent is where the inventor defines the scope of the invention. It includes independent claims, which stand alone, and dependent claims, which refer back to the independent claims. The number and complexity of these claims can significantly impact the patent's scope and enforceability[3].

Independent Claims

Independent claims are the cornerstone of a patent's scope. They define the invention in its broadest terms without referencing other claims. For example, in the context of drug delivery systems, an independent claim might describe a novel method of administering a drug without specifying the exact mechanism.

Dependent Claims

Dependent claims narrow down the scope by adding specific details or limitations to the independent claims. These claims are often used to protect variations of the invention that are still within the broader scope defined by the independent claims.

Prior Art and Novelty

The novelty of the invention is a key factor in determining the patent's scope. Prior art, which includes all publicly available information before the patent application date, must be considered to ensure the invention is new and non-obvious. For instance, if a drug delivery system similar to the one described in the patent already exists, the scope of the patent might be limited to the unique aspects of the new invention.

Patent Landscape: Related Patents and Technologies

Drug Delivery Systems

Patents like US8357114B2, which describe drug dispensing devices with flexible push rods, illustrate the complexity and innovation in drug delivery systems. These patents often overlap in their scope, with each focusing on a specific aspect of drug delivery, such as dosage forms, administration methods, or device design[1].

Sufentanil and Pain Management

Patents related to sufentanil, such as those protecting Dsuvia, highlight the extensive patent landscape in pain management. These patents cover various aspects like dosage forms, modes of administration, and specific formulations, ensuring a broad protection for the drug and its delivery methods[5].

Industry Experts and Quotes

Industry experts often emphasize the importance of a well-defined patent scope. For example, Stelios Tzannis, an inventor with numerous patents in the field of drug delivery, underscores the need for precise and narrow claims to avoid litigation and ensure the validity of the patent[2].

Statistics and Trends

  • Patent Maintenance Payments: Patents with narrower claims tend to have higher maintenance payment compliance rates, indicating a stronger likelihood of grant and shorter examination processes[3].
  • Forward Citations: Patents with broader claims often receive fewer forward citations, suggesting a lower impact on subsequent innovations[3].

Implications for Innovators and Investors

Understanding the scope and claims of a patent like 10,507,180 is vital for innovators and investors. Here are some key implications:

Innovation Incentives

A well-defined patent scope can incentivize further innovation by providing clear boundaries and encouraging improvements rather than duplications.

Litigation Risks

Broad or overly vague claims can lead to increased litigation costs and risks, making it crucial to ensure claims are precise and enforceable.

Market Strategy

Knowing the patent landscape helps in developing a market strategy that avoids infringement and leverages the unique aspects of the patented invention.

Case Studies and Examples

Dsuvia Patent Example

The Dsuvia patents, which protect sufentanil solid dosage forms and oral transmucosal dosage forms, demonstrate how multiple patents can cover different aspects of a single drug. This strategy ensures comprehensive protection and highlights the complexity of the patent landscape in pharmaceuticals[5].

Key Takeaways

  • Patent Scope Metrics: Independent claim length and count are crucial metrics for measuring patent scope.
  • Claims Structure: Independent and dependent claims define the invention's scope and variations.
  • Prior Art and Novelty: Ensuring the invention is new and non-obvious is essential for patent validity.
  • Industry Trends: Narrower claims are associated with higher grant probabilities and shorter examination processes.
  • Market Implications: Clear patent scopes incentivize innovation, reduce litigation risks, and inform market strategies.

FAQs

Q: What are the key metrics for measuring patent scope? A: Independent claim length and independent claim count are two simple yet effective metrics for measuring patent scope[3].

Q: How do dependent claims affect the patent scope? A: Dependent claims narrow down the scope by adding specific details or limitations to the independent claims, protecting variations of the invention.

Q: Why is prior art important in patent applications? A: Prior art ensures the invention is new and non-obvious, which is crucial for patent validity.

Q: What are the implications of broad or overly vague claims? A: Broad or overly vague claims can lead to increased litigation costs and risks, and may receive fewer forward citations, indicating a lower impact on subsequent innovations[3].

Q: How does the patent landscape in pharmaceuticals impact innovation? A: The patent landscape in pharmaceuticals, with multiple patents covering different aspects of a drug, ensures comprehensive protection and encourages further innovation by defining clear boundaries.

Sources

  1. US8357114B2 - Drug dispensing device with flexible push rod - Google Patents
  2. Stelios Tzannis Inventions, Patents and Patent Applications - Justia
  3. Patent Claims and Patent Scope - SSRN
  4. Sufentanil: Uses, Interactions, Mechanism of Action - DrugBank Online
  5. Dsuvia patent expiration - Pharsight - GreyB

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,507,180

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vertical Pharms DSUVIA sufentanil citrate TABLET;SUBLINGUAL 209128-001 Nov 2, 2018 DISCN Yes No 10,507,180 ⤷  Try for Free Y TREATMENT OF ACUTE PAIN ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,507,180

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2114383 ⤷  Try for Free 300797 Netherlands ⤷  Try for Free
European Patent Office 2114383 ⤷  Try for Free CA 2016 00007 Denmark ⤷  Try for Free
European Patent Office 2114383 ⤷  Try for Free CR 2016 00007 Denmark ⤷  Try for Free
European Patent Office 2114383 ⤷  Try for Free 122016000023 Germany ⤷  Try for Free
European Patent Office 2114383 ⤷  Try for Free 16C0010 France ⤷  Try for Free
European Patent Office 2114383 ⤷  Try for Free SPC/GB16/004 United Kingdom ⤷  Try for Free
Austria E474564 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.